Exicure, Inc.(XCUR)
Biotechnology
Oncology Biotech
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-01-21 | Exicure HiTron Inc. 10% Owner | Sale | -258,367 | -4.98%4,932,280 | $4.50 | $1,162,652 | View SEC filing | |
| 2026-01-20 | Exicure HiTron Inc. 10% Owner | Sale | -734,747 | -12.40%5,190,647 | $4.50 | $3,306,362 | View SEC filing | |
| 2026-01-08 | Exicure HiTron Inc. 10% Owner | Sale | -741,272 | -11.12%5,925,394 | $4.50 | $3,335,724 | View SEC filing | |
| 2025-12-10 | SANGSANGIN INVESTMENT & SECURITIES CO., LTD. 10% Owner | Sale | -433,332 | -100.00%0 | $8.71 | $3,774,322 | View SEC filing | |
| 2025-03-26 | HiTron Systems Inc. 10% Owner | Purchase | +2,900,000 | +76.99%6,666,666 | $3.00 | $8,700,000 | View SEC filing | |
| 2024-09-16 | DGP Co., Ltd. 10% Owner | Purchase | +237,223 | +38.76%849,223 | $3.00 | $711,669 | View SEC filing | |
| 2024-03-04 | DGP Co., Ltd. 10% Owner | Sale | -3,400,000 | -100.00%0 | $1.32 | $4,488,000 | View SEC filing | |
| 2022-12-19 | CBI USA, Inc. 10% Owner | Purchase | +3,400,000 | +415.50%4,218,299 | $1.60 | $5,440,000 | View SEC filing | |
| 2022-05-19 | Muralidhar Bali Director | Purchase | +1,472,126 | +21.10%8,449,126 | $0.19 | $285,151 | View SEC filing | |
| 2021-12-22 | GATES WILLIAM H III 10% Owner | Sale | -1,268,619 | -20.03%5,064,703 | $0.24 | $303,200 | View SEC filing | |
| 2021-09-08 | Papadimas Elias D. Chief Accounting Officer | Purchase | +10,000 | +100.00%10,000 | $1.38 | $13,800 | View SEC filing | |
| 2020-06-16 | AURASENSE LLC 10% Owner | Sale | -10,195 | -0.09%11,257,629 | $2.83 | $28,852 | View SEC filing | |
| 2020-06-16 | Mirkin Chad A. Director, 10% Owner | Sale | -10,195 | -0.09%11,381,214 | $2.83 | $28,852 | View SEC filing | |
| 2020-03-16 | WALT DAVID R Director | Purchase | +291,066 | +16.47%2,058,777 | $1.21 | $352,859 | View SEC filing | |
| 2020-03-16 | SNYDER DAVID S Chief Financial Officer | Purchase | +18,248 | +100.00%18,248 | $1.40 | $25,591 | View SEC filing | |
| 2020-03-16 | Mirkin Chad A. Director, 10% Owner | Purchase | +15,000 | +100.00%15,000 | $1.45 | $21,750 | View SEC filing | |
| 2019-12-23 | Muralidhar Bali Director | Purchase | +727,000 | +11.63%6,977,000 | $2.75 | $1,999,250 | View SEC filing | |
| 2019-08-06 | Mirkin Chad A. Director, 10% Owner | Purchase | +25,000 | +100.00%25,000 | $2.00 | $50,000 | View SEC filing | |
| 2019-08-06 | Venkatesan Jay Director | Purchase | +250,000 | +478.62%302,234 | $2.00 | $500,000 | View SEC filing | |
| 2019-08-06 | WALT DAVID R Director | Purchase | +1,000,000 | +130.26%1,767,711 | $2.00 | $2,000,000 | View SEC filing | |
| 2019-03-22 | Mirkin Chad A. Director, 10% Owner | Purchase | +500 | +1.87%27,267 | $2.30 | $1,150 | View SEC filing | |
| 2019-03-21 | Mirkin Chad A. Director, 10% Owner | Purchase | +1,000 | +3.88%26,767 | $2.43 | $2,430 | View SEC filing | |
| 2019-03-19 | Giljohann David A Chief Executive Officer | Purchase | +7,000 | +42.00%23,666 | $2.40 | $16,800 | View SEC filing | |
| 2019-03-18 | Mirkin Chad A. Director, 10% Owner | Purchase | +1,000 | +4.04%25,767 | $2.40 | $2,400 | View SEC filing | |
| 2019-03-14 | Mirkin Chad A. Director, 10% Owner | Purchase | +2,200 | +9.75%24,767 | $2.50 | $5,500 | View SEC filing |
1-25 of 31